1 / 8

Microbiome Therapeutic Market

Microbiome Therapeutic Market

Mayuri24
Download Presentation

Microbiome Therapeutic Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Microbiome Therapeutic Market Trends, Size, Share, Demands, Overview, Growth, Revenue and Forecast to 2030 sales@delvens.comwww.delvens.com

  2. Sternal Closure Systems Market – Trends Forecast Till 2030 Microbiome Therapeutics Market Size, Share & Trends Analysis Report by Type (FMT, Microbiome Drugs), By Application (C. difficile, Crohn's Disease, Inflammatory Bowel Disease, Diabetes) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America). Request For Free Sample Report: https://www.delvens.com/get-free-sample/microbiome-therapeutic-market sales@delvens.com www.delvens.com

  3. Market Overview The microbiome is a collection of genetic material derived from all of the bacteria that inhabit the human body. When compared to the human genome, the genome of bacteria contains 200 times the number of genes. There are hundreds of distinct bacterial species in the microbiome, with the majority of them found mostly in the mouth, vagina, and mouth. The gut microbiome is a crucial component of the immune system since it aids in the regulation of digestion and the improvement of immunity. The balance of microorganisms is critical since it may lead to weight gain, high cholesterol, excessive blood sugar, and other illnesses if it is out of balance. Industry analysts have examined the technical and commercial business prospects for the Microbiome therapies industry in this highly specialized and expertise-oriented industry research study. The rising prevalence of obesity is expected to propel the growth of the microbiome therapeutics market. Sedentary lifestyles, busy work lives, and unhealthy food choices are gradually becoming the leading causes of obesity globally. Growing urbanization and busy lifestyles are leading to an increasing preference for packaged and processed foods and physical inactivity. Purchase this Report: https://www.delvens.com/checkout/microbiome-therapeutic-market sales@delvens.com www.delvens.com

  4. Key Findings The Microbiome Therapeutic Market is segmented into type, application, and region: The microbiome is a collection of genetic material derived from all of the bacteria that inhabit the human body. When compared to the human genome, the genome of bacteria contains 200 times the number of genes. There are hundreds of distinct bacterial species in the microbiome, with the majority of them found mostly in the mouth, vagina, and mouth. The type segment is further bifurcated into FMT and Microbiome Drugs. Fecal microbiota therapy (FMT) dominated the microbiome therapeutics market in 2021 and is anticipated to dominate the market in the future. sales@delvens.com www.delvens.com

  5. Key Findings The application segment is further segmented into C. difficile, Crohn’s disease, Inflammatory Bowel Disease, Diabetes, and Others. The market is also divided into various regions such as North America, Europe, Asia-Pacific, South America, and Middle East and Africa. North America is estimated to account for the largest market share during the forecast period. Inquire Before Buying: https://www.delvens.com/Inquire-before-buying/microbiome-therapeutic-market sales@delvens.com www.delvens.com

  6. Competitive Landscape • OpenBiome • Seres Therapeutics Inc. • 4D Pharma plc. • Locus Biosciences, Inc. • Enterome SA • Finch Therapeutics Group, Inc. • Intralytix, Inc. • Microbiotica • Second Genome • Rebiotix Inc. • Vedanta Bioscience, Inc sales@delvens.com www.delvens.com

  7. Recent Developments In 2022, OptiBiotix Health Plc. signed an exclusive sales and distribution agreement with Nahdi Medical Co. To help tackle the obesity epidemic, the company’s GoFigure and SlimBiome Medical weight management products will be available in the KSA from early 2022 through the new agreement with Nahdi. In 2020, 4D Pharma merged with Longevity Acquisition Corporation to gain a NASDAQ listing. In turn, Longevity will support and accelerate the ongoing development of 4D pharma’s Live Biotherapeutic. Live Biotherapeutics is a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacterium, that is applicable to the prevention, treatment, or cure of a disease. sales@delvens.com www.delvens.com

  8. Contact Information About Us: Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally. Contact Us: +44-20-3290-6466 +1 214-377-1144 sales@delvens.com sales@delvens.com www.delvens.com

More Related